From market question to market execution.

AI-native market entry platform for pharma, biotech, and medtech teams, across 90+ markets including all 50 US states.

MARKET BRIEF 🇻🇳
COMPARE 🇧🇷🇨🇴🇲🇽
TOP 5 🌏
GVD 🇮🇩
PRICING 🇨🇱
REG TRACKER 🇵🇭
MARKET BRIEF
MARKET BRIEF
Vietnam · GLP-1 Receptor Agonist
DECISIONEnter with conditions: BHYT formulary listing required; 18-24 month access timeline.
Two doors, one platform

Which are you bringing to market?

The data underneath is the same across 90+ markets. What leads, and how the decision is framed, differs by track.

Medtech track

Medtech and diagnostics

Conformity routes, reference agency reliance, procurement and local representation, read for a device.

  • IVDs and diagnostics
  • Medical devices, Class I to III
  • Software as a medical device
  • Digital health and connected devices
  • Imaging and capital equipment
Explore the medtech track →
Pharma track

Pharma and biotech

Approval, HTA, reference pricing and formulary access, read for a therapeutic.

  • Small molecules and drugs
  • Biologics and biosimilars
  • Specialty and rare disease
  • Vaccines
  • Biotech therapeutics
Explore the pharma track →
90
Markets covered
Cited
To primary sources
$20-40K
Typical consultant quote
The framework

Six dimensions, rated the same way in every market

Each one rated Ready, Moderate, or Complex, calibrated to your product type and the clearances you already hold. No composite score, no weighted average.

01

Regulatory pathway

The approval or conformity route your existing clearances open, whether the authority runs a reliance route, and which agencies it treats as reference.

02

Timeline

The published clock for the route you qualify for, in the regulator’s own units, or marked as unpublished.

03

Procurement structure

Who actually buys, tender, formulary, hospital group or distributor tier, and what registration or listing status is required.

04

Pricing environment

How price is set and constrained, and the effect of a first accepted price on the markets that price against it.

05

Local partner requirements

The representative, agent, sponsor or licensed establishment the market requires, and whether it must exist before the clock starts.

06

Tax and customs

Import duty, customs treatment, and the free-zone question.

The workflow

Map. Decide. Execute

Illustrative walkthrough: a Class II device entering Indonesia. Eight tools across three stages, each output feeding the next. Each step names the ones it draws on.

The same six dimensions, published on SSRN. Example shown for illustration; every live brief runs on your product and markets.

01 · Map
Map
Market Brief · Compare Markets · Top 5 Markets
02 · Decide
Decide
Global Value Dossier · Pricing & Evidence Simulator · Scenario Planner
03 · Execute
Execute
Regulatory Tracker · Vantro Match
Market Brief · Compare Markets2 of 3 sourced

Map the landscape. A single-market read on Indonesia, then benchmarked against the Philippines and Vietnam across the six dimensions that decide entry.

Regulatory route
Full BPOM review, no reliance route
BPOM
Time to market
6 to 9 months to approval
BPOM
Access condition
Distributor must hold the registration
No evidence

Contact us.

Whether you have a specific market question, want to book a call, or are interested in a subscription, drop us a message.

Or
Book a 30 min call →

30 minutes. We'll walk you through the platform and answer any questions about your specific markets and product type.